Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.

Secardin L, Gomez Limia C, da Silva-Benedito S, Lordier L, El-Khoury M, Marty C, Ianotto JC, Raslova H, Constantinescu SN, Bonamino MH, Vainchenker W, Monte-Mor B, Di Stefano A, Plo I

Open source

DOI: 10.1097/hs9.0000000000000593
Published: 2021 Jul
Container: HemaSphere
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/hs9.0000000000000593,
  title = {Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.},
  author = {Secardin L and Gomez Limia C and da Silva-Benedito S and Lordier L and El-Khoury M and Marty C and Ianotto JC and Raslova H and Constantinescu SN and Bonamino MH and Vainchenker W and Monte-Mor B and Di Stefano A and Plo I},
  year = {2021},
  journal = {HemaSphere},
  doi = {10.1097/hs9.0000000000000593},
  url = {https://doi.org/10.1097/hs9.0000000000000593}
}

RIS

TY  - JOUR
TI  - Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.
AU  - Secardin L
AU  - Gomez Limia C
AU  - da Silva-Benedito S
AU  - Lordier L
AU  - El-Khoury M
AU  - Marty C
AU  - Ianotto JC
AU  - Raslova H
AU  - Constantinescu SN
AU  - Bonamino MH
AU  - Vainchenker W
AU  - Monte-Mor B
AU  - Di Stefano A
AU  - Plo I
PY  - 2021
JO  - HemaSphere
DO  - 10.1097/hs9.0000000000000593
UR  - https://doi.org/10.1097/hs9.0000000000000593
ER  -

APA

L, S., C, G. L., S, D. S., L, L., M, E., C, M., JC, I., H, R., SN, C., MH, B., W, V., B, M., A, D. S., & I, P. (2021). Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms.. HemaSphere. https://doi.org/10.1097/hs9.0000000000000593

Source records

pubmed · retrieved 2026-09-26T09:48:24.935Z
europe-pmc · retrieved 2026-09-26T09:48:24.949Z
doaj · retrieved 2026-09-26T09:48:24.928Z
hal · retrieved 2026-09-26T09:48:24.969Z